Literature DB >> 10672914

Biology of renal aging in humans.

B Clark1.   

Abstract

Advancing age is usually accompanied by a decline in glomerular filtration rate and an increased incidence of certain renal and electrolyte disorders. These include an increased susceptibility to acute renal failure, hypo- and hypernatremia, hyperkalemia, and hypertension. This report discusses anatomic and physiological observations related to the aged human kidney and explores the various theories and postulated mechanisms underlying these changes.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10672914     DOI： 10.1016/s1073-4449(00)70002-1

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN： 1073-4449


  13 in total

Review 1.  Molecular physiology of urinary concentration defect in elderly population.

Authors:  B K Kishore; C M Kran; M Reif; A G Menon
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.

Authors:  Dagmar Kubitza; Michael Becka; Wolfgang Mueck; Atef Halabi; Haidar Maatouk; Norbert Klause; Volkmar Lufft; Dominic D Wand; Thomas Philipp; Heike Bruck
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 3.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 4.  Unexplained anemia in the elderly.

Authors:  Sasan Makipour; Bindu Kanapuru; William B Ershler
Journal:  Semin Hematol       Date:  2008-10       Impact factor: 3.851

5.  Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes.

Authors:  Xu Steven Xu; Kenneth Moore; Paul Burton; Kim Stuyckens; Wolfgang Mueck; Stefaan Rossenu; Alexei Plotnikov; Michael Gibson; An Vermeulen
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

6.  Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.

Authors:  Wolfgang Mueck; Anthonie W A Lensing; Giancarlo Agnelli; Hervé Decousus; Paolo Prandoni; Frank Misselwitz
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

7.  Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure.

Authors:  Pedro Gomes; Sónia Simão; Elisabete Silva; Vanda Pinto; João S Amaral; Joana Afonso; Maria Paula Serrão; Maria João Pinho; Patrício Soares-da-Silva
Journal:  Oxid Med Cell Longev       Date:  2009 Jul-Aug       Impact factor: 6.543

8.  Omega-3 and renal function in older adults.

Authors:  F Lauretani; M Maggio; F Pizzarelli; S Michelassi; C Ruggiero; G P Ceda; S Bandinelli; L Ferrucci
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  The geriatric population and psychiatric medication.

Authors:  Sannidhya Varma; Himanshu Sareen; J K Trivedi
Journal:  Mens Sana Monogr       Date:  2010-01

Review 10.  (Healthy) ageing: focus on iodothyronines.

Authors:  Pieter de Lange; Federica Cioffi; Elena Silvestri; Maria Moreno; Fernando Goglia; Antonia Lanni
Journal:  Int J Mol Sci       Date:  2013-07-04       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.